Hosted on MSN

Recursion Pharmaceuticals reports positive Phase 1b/2 TUPELO trial results, validating AI-driven therapy for FAP

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion Pharmaceuticals announced positive Phase 1b/2 results from its ongoing TUPELO trial ...
MIT Technology Review

LLMs contain a LOT of parameters. But what’s a parameter?

They’re the mysterious numbers that make your favorite AI models tick. What are they and what do they do? MIT Technology Review Explains: Let our writers untangle the complex, messy world of ...